ESR1 and breast carcinoma: A recent study showed that DNA methylation at enhancers and ERα binding sites may participate in ER positive breast cancer resistance to anti-estrogen treatment39, and in addition, ERα binding regions have been suggested to be altered by DNA methylation with effects on gene expression40.